Burnham Institute for Medical Research Appoints First Chief Business Officer

LA JOLLA, Calif.--(BUSINESS WIRE)--Burnham Institute for Medical Research (Burnham) announced today that Dr. Paul Laikind will join Burnham as Senior Vice President, Business Development and Chief Business Officer in November. Dr. Laikind is a seasoned entrepreneur with extensive experience in business development. He is the cofounder of three biotech companies – Gensia Pharmaceuticals, Viagene and Metabasis Therapeutics. He most recently served as the President and CEO of Metabasis and remains a member of the board of directors.

MORE ON THIS TOPIC